Jim Cramer commented on several mergers while answering viewers’ social media questions from the floor of the New York Stock Exchange on Monday. Cramer, who’s portfolio manager of TheStreet’s Action Alerts Plus and host of CNBC’s ‘Mad Money,’ was asked when Pfizer (PFE) and Allergan (AGN) will merge. Cramer believes the two companies won’t unite until the third quarter of next year because it’s a complex merger, but he added that he’s not worried about the tax inversion issue. Cramer also talked about JAB Holding’s purchase of Keurig Green Mountain (GMCR) for $13.9 billion, saying it’s a great deal for Green Mountain. Coca-Cola (KO), which is Keurig’s biggest single shareholder, has said it is supportive of the deal. On the recent news that Amazon (AMZN) is teaming up with Baidu (BIDU)on the content side, Cramer said investors should continue to buy Amazon. Cramer commented on a few retailers, saying Rite Aid (RAD) is a stock to hold onto, and that when Macy’s (M) stock falls to $35, it might be time to pull the trigger. Send your questions to Jim Cramer on Facebook and Twitter - @JimCramer, using #CramerQ.
More from Video
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Breaking down an approach to the long side of this biotech stock.